SCHEMBL1869759

SCHEMBL1869759

CCCC(CO)S(N)(=O)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 11/20 0.43
CA2 P00918 11/20 0.43
CA7 P43166 2/20 0.43
CA14 Q9ULX7 2/20 0.43
CA12 O43570 1/20 0.43
TSHR P16473 3/20 0.39
CHRM1 P11229 1/20 0.37
AKR1A1 P14550 1/20 0.37
CHRM3 P20309 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
ADRA1A P35348 1/20 0.37
HRH1 P35367 1/20 0.37
DRD3 P35462 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CYP3A4 P08684 2/20 0.36
NFKB1 P19838 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL276258 0.85 CA2 (0.50) CA1CA2CA7CA14CA12
SCHEMBL28021944 0.84 CA1 (0.42) CA1CA2CA7CA14CA12
SCHEMBL11682952 0.80 TSHR (0.42) CA1CA2CA7CA14CA12
SCHEMBL222112 0.80 CA2 (0.46) CA1CA2CA7CA14CA12
Hydrochloric Acid SCHEMBL28651381 0.78 CA2 (0.45) CA1CA2CA7CA14CA12
SCHEMBL276801 0.76 CA2 (0.43) CA1CA2CA7CA14CA12
SCHEMBL28480577 0.74 TP53 (0.47) CA1CA2CA7CA14CA12
SCHEMBL276173 0.73 CA2 (0.47) CA1CA2CA7CA14CA12
SCHEMBL23670874 0.71 CA2 (0.42) CA2
SCHEMBL19284905 0.71 CA2 (0.42) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496575-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVES USEFUL AS MEK INHIBITORS Novartis AG (CH) 2012-09-12 EP disclosed
WO-2011054828-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVES USEFUL AS MEK INHIBITORS NOVARTIS AG (CH) 2011-05-12 WO disclosed